Lo más citado
- •
Obstructive sleep apnea affects one billion people worldwide and is associated with cardiometabolic risk and cognitive impairment.
- •
Drug therapy for the management of sleep apnea has been investigated, but no robust evidence that supports its benefits has been found to date.
- •
The combination of noradrenergic and antimuscarinic drugs shows promising results.
- •
Low HDL-C and high ferritin are linked to increased Long-COVID-19 severity.
- •
Changes in HDL-C levels, significantly impact Long-COVID-19 progression.
- •
Ferritin may exacerbate disease progression by increasing oxidative stress.
- •
HDL-C and ferritin levels may serve as markers and therapeutic targets for Long-COVID-19.
- •
Panoramic radiography is suitable for determining vertical bone loss around mini-implants.
- •
Questionable implant sites are to be evaluated in cooperation with one other expert.
- •
Unquantifiable implant sites are to be excluded regarding therapy decisions.
- •
Mutual calibration sessions for bone level measurements are highly recommended.